In this article, Ben Hargreaves looks into the promise of cancer vaccines and how this treatment modality may offer advantages over existing immunotherapies in the oncology sector.
Despite its best efforts to streamline and transform itself into a good buy for prospective purchasers, biotech Dendreon has had no offers and has had to file for Chapter 11 bankruptcy prot
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.